| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | spectrin | 3.07e-04 | 9 | 62 | 2 | GO:0008091 | |
| GeneOntologyCellularComponent | cell-cell junction | 3.43e-04 | 591 | 62 | 8 | GO:0005911 | |
| GeneOntologyCellularComponent | paranodal junction | 4.68e-04 | 11 | 62 | 2 | GO:0033010 | |
| GeneOntologyCellularComponent | fascia adherens | 6.61e-04 | 13 | 62 | 2 | GO:0005916 | |
| MousePheno | decreased birth body size | 6.23e-05 | 232 | 42 | 6 | MP:0009703 | |
| MousePheno | abnormal birth body size | 7.02e-05 | 237 | 42 | 6 | MP:0009701 | |
| Domain | Spectrin | 5.07e-05 | 23 | 59 | 3 | PF00435 | |
| Domain | Spectrin_repeat | 1.03e-04 | 29 | 59 | 3 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 1.39e-04 | 32 | 59 | 3 | IPR018159 | |
| Domain | SPEC | 1.39e-04 | 32 | 59 | 3 | SM00150 | |
| Domain | Cadherin_pro | 2.04e-04 | 7 | 59 | 2 | PF08758 | |
| Domain | Cadherin_pro_dom | 2.71e-04 | 8 | 59 | 2 | IPR014868 | |
| Domain | Cadherin_pro | 2.71e-04 | 8 | 59 | 2 | SM01055 | |
| Domain | C1_1 | 7.76e-04 | 57 | 59 | 3 | PF00130 | |
| Domain | ZF_DAG_PE_1 | 1.09e-03 | 64 | 59 | 3 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 1.09e-03 | 64 | 59 | 3 | PS50081 | |
| Domain | C1 | 1.14e-03 | 65 | 59 | 3 | SM00109 | |
| Domain | PE/DAG-bd | 1.19e-03 | 66 | 59 | 3 | IPR002219 | |
| Domain | Actinin_actin-bd_CS | 2.38e-03 | 23 | 59 | 2 | IPR001589 | |
| Domain | G_patch | 2.38e-03 | 23 | 59 | 2 | SM00443 | |
| Domain | G_patch_dom | 2.38e-03 | 23 | 59 | 2 | IPR000467 | |
| Domain | G_PATCH | 2.38e-03 | 23 | 59 | 2 | PS50174 | |
| Domain | G-patch | 2.38e-03 | 23 | 59 | 2 | PF01585 | |
| Domain | ACTININ_2 | 2.38e-03 | 23 | 59 | 2 | PS00020 | |
| Domain | ACTININ_1 | 2.38e-03 | 23 | 59 | 2 | PS00019 | |
| Domain | Cadherin_cytoplasmic-dom | 2.81e-03 | 25 | 59 | 2 | IPR000233 | |
| Domain | Cadherin_C | 2.81e-03 | 25 | 59 | 2 | PF01049 | |
| Domain | Catenin_binding_dom | 3.77e-03 | 29 | 59 | 2 | IPR027397 | |
| Domain | - | 3.77e-03 | 29 | 59 | 2 | 4.10.900.10 | |
| Pathway | WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME | 1.70e-04 | 34 | 45 | 3 | M42555 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ESTABLISHMENT_OF_COHESION | 2.07e-04 | 7 | 45 | 2 | M47869 | |
| Pathway | REACTOME_COHESIN_LOADING_ONTO_CHROMATIN | 4.41e-04 | 10 | 45 | 2 | M27178 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 4.41e-04 | 10 | 45 | 2 | MM15112 | |
| Pathway | REACTOME_COHESIN_LOADING_ONTO_CHROMATIN | 4.41e-04 | 10 | 45 | 2 | MM14892 | |
| Pathway | REACTOME_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION | 5.38e-04 | 11 | 45 | 2 | M27177 | |
| Pathway | REACTOME_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION | 5.38e-04 | 11 | 45 | 2 | MM14891 | |
| Pathway | REACTOME_MITOTIC_TELOPHASE_CYTOKINESIS | 7.60e-04 | 13 | 45 | 2 | M27661 | |
| Pathway | REACTOME_MITOTIC_TELOPHASE_CYTOKINESIS | 7.60e-04 | 13 | 45 | 2 | MM15363 | |
| Pubmed | Agrin has a pathological role in the progression of oral cancer. | 1.44e-06 | 197 | 62 | 6 | 29872149 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | PDS5B REXO4 DNAJC13 CDC42BPA SYNE1 SPTAN1 SPTBN2 SUGP1 PDS5A TSG101 CPSF2 | 2.99e-06 | 1082 | 62 | 11 | 38697112 |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 8247017 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 35986423 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 31757807 | ||
| Pubmed | Characterization of a new beta-spectrin gene which is predominantly expressed in brain. | 3.13e-06 | 2 | 62 | 2 | 9675416 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 23357422 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 34070827 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 10662782 | ||
| Pubmed | 3.61e-06 | 58 | 62 | 4 | 24144296 | ||
| Pubmed | Pds5B is required for cohesion establishment and Aurora B accumulation at centromeres. | 9.37e-06 | 3 | 62 | 2 | 24141881 | |
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 31066256 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 28343969 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 1406710 | ||
| Pubmed | MRPL17 MRPS7 DNAJC13 PPP2R5D CDC42BPA SYNE1 SPTAN1 SPTBN2 TTC13 EMC2 BCS1L HELLS | 1.06e-05 | 1487 | 62 | 12 | 33957083 | |
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 16461340 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 29217591 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 14561752 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 9015265 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 32285610 | ||
| Pubmed | Calcium-dependent adhesion is necessary for the maintenance of prosomeres. | 3.12e-05 | 5 | 62 | 2 | 11319859 | |
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 12865344 | ||
| Pubmed | Cell binding specificity of mouse R-cadherin and chromosomal mapping of the gene. | 3.12e-05 | 5 | 62 | 2 | 8270638 | |
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 10698974 | ||
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 15837422 | ||
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 8612964 | ||
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 15572153 | ||
| Pubmed | ST3GAL1 and βII-spectrin pathways control CAR T cell migration to target tumors. | 4.67e-05 | 6 | 62 | 2 | 37069398 | |
| Pubmed | In vivo assembly of the axon initial segment in motor neurons. | 4.67e-05 | 6 | 62 | 2 | 23728480 | |
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 35602553 | ||
| Pubmed | Spectrins and ankyrinB constitute a specialized paranodal cytoskeleton. | 4.67e-05 | 6 | 62 | 2 | 16687515 | |
| Pubmed | 6.18e-05 | 560 | 62 | 7 | 35241646 | ||
| Pubmed | Genetic dissection of cadherin function during nephrogenesis. | 6.53e-05 | 7 | 62 | 2 | 11839813 | |
| Pubmed | 6.53e-05 | 7 | 62 | 2 | 15855230 | ||
| Pubmed | 6.53e-05 | 7 | 62 | 2 | 19412548 | ||
| Pubmed | Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization. | 8.69e-05 | 8 | 62 | 2 | 29867216 | |
| Pubmed | 8.69e-05 | 8 | 62 | 2 | 21699228 | ||
| Pubmed | DNAJC13 PPP2R5D CDC42BPA SLC12A4 SPTAN1 SPTBN2 PINX1 CPSF2 HELLS | 9.64e-05 | 1049 | 62 | 9 | 27880917 | |
| Pubmed | 1.12e-04 | 9 | 62 | 2 | 17349791 | ||
| Pubmed | 1.12e-04 | 9 | 62 | 2 | 16682347 | ||
| Pubmed | 1.12e-04 | 9 | 62 | 2 | 17112726 | ||
| Pubmed | Scc1 sumoylation by Mms21 promotes sister chromatid recombination through counteracting Wapl. | 1.39e-04 | 10 | 62 | 2 | 22751501 | |
| Pubmed | Cell organization, growth, and neural and cardiac development require αII-spectrin. | 1.39e-04 | 10 | 62 | 2 | 22159418 | |
| Pubmed | Diversity of the cadherin family: evidence for eight new cadherins in nervous tissue. | 1.39e-04 | 10 | 62 | 2 | 2059658 | |
| Pubmed | 1.39e-04 | 10 | 62 | 2 | 23242214 | ||
| Pubmed | 1.39e-04 | 10 | 62 | 2 | 27151949 | ||
| Pubmed | Sororin mediates sister chromatid cohesion by antagonizing Wapl. | 1.39e-04 | 10 | 62 | 2 | 21111234 | |
| Pubmed | Brain proteins interacting with the tetramerization region of non-erythroid alpha spectrin. | 1.70e-04 | 11 | 62 | 2 | 17607528 | |
| Pubmed | Wapl controls the dynamic association of cohesin with chromatin. | 1.70e-04 | 11 | 62 | 2 | 17113138 | |
| Pubmed | 1.70e-04 | 11 | 62 | 2 | 9367432 | ||
| Pubmed | Mouse R-cadherin: expression during the organogenesis of pancreas and gastrointestinal tract. | 1.70e-04 | 11 | 62 | 2 | 7493641 | |
| Pubmed | 1.70e-04 | 11 | 62 | 2 | 22293751 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 1.99e-04 | 1155 | 62 | 9 | 20360068 | |
| Pubmed | MRPL17 MRPS7 YEATS2 REXO4 CDC42BPA SPTAN1 SUGP1 PDS5A CPSF2 HELLS | 2.04e-04 | 1429 | 62 | 10 | 35140242 | |
| Pubmed | 2.41e-04 | 13 | 62 | 2 | 18796539 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 2.84e-04 | 954 | 62 | 8 | 36373674 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | 2.88e-04 | 719 | 62 | 7 | 35337019 | |
| Pubmed | 3.02e-04 | 963 | 62 | 8 | 28671696 | ||
| Pubmed | Ankyrin-G regulated epithelial phenotype is required for mouse lens morphogenesis and growth. | 3.23e-04 | 15 | 62 | 2 | 30562487 | |
| Pubmed | 3.23e-04 | 15 | 62 | 2 | 18507827 | ||
| Pubmed | 3.23e-04 | 15 | 62 | 2 | 23901111 | ||
| Pubmed | 3.23e-04 | 15 | 62 | 2 | 33833667 | ||
| Pubmed | 3.23e-04 | 15 | 62 | 2 | 30735538 | ||
| Pubmed | Cadherin expression in the developing mouse olfactory system. | 3.69e-04 | 16 | 62 | 2 | 17278136 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 3.98e-04 | 759 | 62 | 7 | 35915203 | |
| Pubmed | 4.31e-04 | 197 | 62 | 4 | 36604605 | ||
| Pubmed | Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. | 4.70e-04 | 18 | 62 | 2 | 12119179 | |
| Pubmed | Combined analysis of three genome-wide association studies on vWF and FVIII plasma levels. | 4.70e-04 | 18 | 62 | 2 | 21810271 | |
| Pubmed | E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton. | 5.82e-04 | 20 | 62 | 2 | 7806582 | |
| Pubmed | Nonmuscle Myosin II Regulates the Morphogenesis of Metanephric Mesenchyme-Derived Immature Nephrons. | 6.42e-04 | 21 | 62 | 2 | 25168025 | |
| Pubmed | 6.74e-04 | 222 | 62 | 4 | 37071664 | ||
| Pubmed | 7.45e-04 | 228 | 62 | 4 | 30471916 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 7.47e-04 | 608 | 62 | 6 | 36089195 | |
| Pubmed | 8.08e-04 | 233 | 62 | 4 | 29518331 | ||
| Pubmed | NDP52 interacts with mitochondrial RNA poly(A) polymerase to promote mitophagy. | 9.14e-04 | 25 | 62 | 2 | 30309841 | |
| Pubmed | 9.14e-04 | 25 | 62 | 2 | 33795534 | ||
| Pubmed | 9.89e-04 | 26 | 62 | 2 | 16280085 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 1.18e-03 | 444 | 62 | 5 | 34795231 | |
| Pubmed | Motor neuron position and topographic order imposed by β- and γ-catenin activities. | 1.23e-03 | 29 | 62 | 2 | 22036570 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | 1.25e-03 | 922 | 62 | 7 | 27609421 | |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | 1.27e-03 | 925 | 62 | 7 | 28986522 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 1.28e-03 | 1201 | 62 | 8 | 35696571 | |
| Pubmed | 1.32e-03 | 30 | 62 | 2 | 22171010 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | 1.41e-03 | 942 | 62 | 7 | 31073040 | |
| Pubmed | 1.43e-03 | 272 | 62 | 4 | 31010829 | ||
| Pubmed | 1.47e-03 | 274 | 62 | 4 | 34244482 | ||
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | 1.48e-03 | 695 | 62 | 6 | 23602568 | |
| Pubmed | 1.50e-03 | 32 | 62 | 2 | 23704327 | ||
| Pubmed | 1.57e-03 | 128 | 62 | 3 | 30995482 | ||
| Pubmed | 1.67e-03 | 971 | 62 | 7 | 33306668 | ||
| Pubmed | 1.69e-03 | 713 | 62 | 6 | 29802200 | ||
| Pubmed | 1.76e-03 | 486 | 62 | 5 | 20936779 | ||
| Cytoband | 19p13.11 | 1.36e-04 | 73 | 62 | 3 | 19p13.11 | |
| GeneFamily | CD molecules|Type I classical cadherins | 5.50e-05 | 5 | 43 | 2 | 1185 | |
| GeneFamily | EF-hand domain containing|Spectrins | 1.15e-04 | 7 | 43 | 2 | 1113 | |
| GeneFamily | G-patch domain containing|Minor histocompatibility antigens | 1.24e-03 | 22 | 43 | 2 | 579 | |
| Coexpression | GSE20715_WT_VS_TLR4_KO_LUNG_DN | 6.97e-06 | 199 | 61 | 6 | M4350 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.70e-06 | 200 | 62 | 5 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.70e-06 | 200 | 62 | 5 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.97e-05 | 158 | 62 | 4 | 7f5426585d0d299d2b48e5fcb349950feffdef33 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.24e-05 | 165 | 62 | 4 | 7c771f22b58989572c939ed127e637ec28dc0dca | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.64e-05 | 167 | 62 | 4 | b94e8ee8c3fcebedd8fcd719eadddc04c7513c50 | |
| ToppCell | Neuroendocrine-neuroendo-1|World / Class top | 1.15e-04 | 180 | 62 | 4 | 50fdd182a083380899b5943cb5f55ffd77e2a7d4 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_2|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.15e-04 | 180 | 62 | 4 | 551b8de8d933d11bcd3897aeb2fd033355f958e2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.18e-04 | 181 | 62 | 4 | 5cecbafc29cc95896e6ccb2c74d9237b9aaece69 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.23e-04 | 183 | 62 | 4 | 310ad42b2b5d8ddd01d3a12db338f80ac1f5d08e | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.23e-04 | 183 | 62 | 4 | fef51dcf180e6d4e136362c7e140ec5ef372e6d0 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.42e-04 | 190 | 62 | 4 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 1.66e-04 | 198 | 62 | 4 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | TCGA-Blood_and_Bone_Marrow-Primary_Tumor-Diffuse_large_B-cell_lymphoma|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9 | 1.69e-04 | 199 | 62 | 4 | 0637e1ae6db9681d86cc21a5fb274dc562604f35 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Vein|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.69e-04 | 199 | 62 | 4 | cfb624c7728046fc7f3ef071f57e4d7b013f3fef | |
| ToppCell | TCGA-Blood_and_Bone_Marrow-Primary_Tumor-Diffuse_large_B-cell_lymphoma-DLBCL|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9 | 1.69e-04 | 199 | 62 | 4 | 076cf7f0994fc6f03b11bc7b51be6dcd9ee41985 | |
| ToppCell | TCGA-Blood_and_Bone_Marrow-Primary_Tumor|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9 | 1.69e-04 | 199 | 62 | 4 | e1be40821330fd273ef54e39d730b31ce0a8f94e | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.73e-04 | 200 | 62 | 4 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.73e-04 | 200 | 62 | 4 | a1fa6bae5a688faf488d6925cd3fad725dfa916b | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.73e-04 | 200 | 62 | 4 | 89a6da2bdedc6b1ad0675c8753bf2b763a99af6a | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / Treatment groups by lineage, cell group, cell type | 1.73e-04 | 200 | 62 | 4 | b036f5e22c95a3b14391785b6e91aa183b9bc9a8 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.73e-04 | 200 | 62 | 4 | b70b7adb7c187e6253c7f0bb4c1f09c85ef7142c | |
| ToppCell | LPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.73e-04 | 200 | 62 | 4 | 1d105eeda5a2c51f9a4654ffc79b7e2348ad593b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.73e-04 | 200 | 62 | 4 | 58a7ece7dfdf6c46f2a50cbcb580574dec14c748 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.73e-04 | 200 | 62 | 4 | d01cec331be3b03cef80e9536fc531285bcf00f6 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.73e-04 | 200 | 62 | 4 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.73e-04 | 200 | 62 | 4 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.73e-04 | 200 | 62 | 4 | 60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.73e-04 | 200 | 62 | 4 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.73e-04 | 200 | 62 | 4 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.73e-04 | 200 | 62 | 4 | 3585484c7e24e941708bee471ca607d8ccee74e6 | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 1.73e-04 | 200 | 62 | 4 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.73e-04 | 200 | 62 | 4 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / Treatment groups by lineage, cell group, cell type | 1.73e-04 | 200 | 62 | 4 | b1fadb2b5e37e0f51e079d8409c2647eef68dc3b | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.73e-04 | 200 | 62 | 4 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 1.73e-04 | 200 | 62 | 4 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.73e-04 | 200 | 62 | 4 | f15fffefe372005c33e31845982e2d2714ac26af | |
| Drug | 1,7-octadiene | 7.31e-08 | 4 | 61 | 3 | CID000019460 | |
| Drug | Cholecalciferol [67-97-0]; Down 200; 10.4uM; PC3; HT_HG-U133A | 8.65e-07 | 194 | 61 | 7 | 6656_DN | |
| Drug | SC-560; Down 200; 10uM; PC3; HT_HG-U133A | 1.50e-05 | 198 | 61 | 6 | 6865_DN | |
| Drug | Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 1.54e-05 | 199 | 61 | 6 | 3860_DN | |
| Disease | intracranial aneurysm (is_marker_for) | 3.76e-04 | 14 | 61 | 2 | DOID:10941 (is_marker_for) | |
| Disease | platelet component distribution width | 9.18e-04 | 755 | 61 | 7 | EFO_0007984 | |
| Disease | response to clopidogrel, cardiovascular event measurement | 1.03e-03 | 23 | 61 | 2 | EFO_0006919, GO_1903493 | |
| Disease | Retinitis Pigmentosa | 1.32e-03 | 104 | 61 | 3 | C0035334 | |
| Disease | azoospermia (implicated_via_orthology) | 1.43e-03 | 27 | 61 | 2 | DOID:14227 (implicated_via_orthology) | |
| Disease | cranial vault morphology measurement | 2.04e-03 | 121 | 61 | 3 | EFO_0009278 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LERKRQEMMENAKWR | 341 | Q9NXE8 | |
| WMSDKLMRCFEDKRN | 286 | Q9P2I0 | |
| MIRIWKVEMREDSAI | 721 | Q8N157 | |
| KWIRVERSREMQMID | 111 | Q9Y276 | |
| RKYMWKTAEDRRMSD | 16 | Q8WTQ4 | |
| RFRMKEREEMWQKIE | 496 | Q14738 | |
| AERMAIRQTWGKERM | 71 | Q9Y2C3 | |
| KSIRMWERKVEIAEM | 336 | Q9H0I3 | |
| RRKMMNEMERKEWAF | 266 | Q7Z4T9 | |
| MWMVKSRQREELVAA | 1521 | Q149M9 | |
| VAMLRGEMFVFKERW | 326 | P50281 | |
| SRIVLMRHGMEKIWR | 171 | Q96S21 | |
| RTLDKRWRVRKEAMM | 396 | Q9NTI5 | |
| RWRVRKEAMMGLAQI | 401 | Q9NTI5 | |
| RTLDKRWRVRKEAMM | 406 | Q29RF7 | |
| RWRVRKEAMMGLAQL | 411 | Q29RF7 | |
| VAARVWREFEMKRMD | 211 | Q9H607 | |
| WDLFRSKDNMRTRIM | 266 | Q8TD20 | |
| MRLLERMRKDWFMVG | 1 | Q0GE19 | |
| WLSMASREDLMKMVR | 131 | A8MTJ6 | |
| RKMLEKARMSWDRES | 46 | Q9NRZ9 | |
| KHEEFRWMRLRIRRM | 231 | Q09328 | |
| CMSELWRMERKRDKN | 136 | Q6UXY1 | |
| EMTSAMKKLWRRDLI | 291 | Q6IF82 | |
| MSMLAERRRKQKWAV | 1 | Q96BK5 | |
| MMRTGAEREALKRRW | 236 | Q8TE49 | |
| LERASTKMLDRWSIM | 446 | Q86XP1 | |
| AEWIQRMMEVLRKRS | 81 | O43927 | |
| RAAQMEKTMRRWSDC | 86 | Q96A19 | |
| LTMVLLFVMWMKRRE | 746 | P55283 | |
| LFVMWMKRREKERHT | 751 | P55283 | |
| AIWSSEMRRLMIEKI | 1201 | O75165 | |
| FMDLLVRRRWEVMSK | 241 | A6NC97 | |
| ELYDVTWEEMRDKMR | 6 | Q15006 | |
| KWKEELLDQRRRMME | 581 | Q9BY12 | |
| MFVVWMKRRDKERQA | 741 | P19022 | |
| MDSALEWLRRELREM | 76 | Q9BTA0 | |
| EMKRALMKLWRRRVV | 296 | Q8NH74 | |
| MVKKEWESMARDRRP | 396 | Q9GZR2 | |
| RAWIRVALMEKRMSE | 126 | Q59EK9 | |
| MALHSMRKARERWSF | 1 | Q9UGM6 | |
| DRRRRFLAMKWMITE | 176 | Q9Y2R9 | |
| RELDWAKVMVEKSRM | 41 | Q96NB2 | |
| MSMERRLKIEETWRL | 7986 | Q8NF91 | |
| MEMRWFLSKIQDDFR | 1 | Q86YW0 | |
| FVEGARRDKWVMKML | 166 | Q9UMX6 | |
| VSRMRGMWRDEKVSL | 111 | Q9BZQ2 | |
| GRFKDWMVSMIVDRE | 86 | P0CL83 | |
| SWDKTERARDMKCLM | 796 | Q9BVR0 | |
| WKMRRFAKLDMSARL | 866 | Q5VT25 | |
| WRKCRMRIFTVAQMD | 871 | Q9UP95 | |
| KRIMKEAFRWALFSM | 181 | Q96AQ7 | |
| DKLRWRMKEEMDRAQ | 236 | Q99816 | |
| WEHQLRRMEMDKTRE | 496 | Q8IWZ8 | |
| RRMEMDKTREWAEQL | 501 | Q8IWZ8 | |
| MMLTDRKEAASWARR | 421 | Q9UNS1 | |
| KTRLMQWRDMFDIAV | 556 | Q8NBP0 | |
| REEKFWMMDIATQRE | 61 | Q9UK11 | |
| VDMMERLRISQKWVR | 1301 | P04275 | |
| MRILVDLERMDWDKA | 351 | P11217 | |
| RFFKAVRELMLWMDE | 1911 | O15020 | |
| MREDRWAVIAKMDRK | 951 | Q15431 | |
| ERADLEKAWVQRRMM | 1426 | Q13813 | |
| GRFKDWMVSMIVDRE | 86 | P0CL84 | |
| CAKKFMWRDSFMRHR | 546 | O15209 | |
| RAAEWQRAMTMRKVL | 1191 | Q9ULM3 | |
| RAMRMADFWLTEKDL | 71 | Q9NRX2 | |
| WFRMVLERRHFLQMK | 966 | Q13459 |